$11.55
-0.43-3.59%
Últ. Act.: Sep 25, 3:26 PM

SELLAS Life Sciences Gr (SLS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.04 | $-0.06 | $-0.06 | $-0.08 |
| Actual | $-0.05 | $-0.05 | $-0.05 | $-0.06 |
| Surprise | -25.0% | +16.7% | +16.7% | +25.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.05 | $-0.05 |
| Revenue | ||
| Consensus | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.05 | $-0.04 | -25.0 % |
| Q1 | May 12, 2026 | $-0.05 | $-0.06 | 16.7 % |
| Q4 | Mar 19, 2026 | $-0.05 | $-0.06 | 16.7 % |
| Q3 | Nov 12, 2025 | $-0.06 | $-0.08 | 25.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 9, 2023 | $0 | $8.67M | -100.0 % |
| Q2 | Aug 10, 2023 | $0 | $3.25M | -100.0 % |